Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$9.78 USD
-0.12 (-1.21%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $9.81 +0.03 (0.31%) 5:38 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Price, Consensus and EPS Surprise
STTK 9.78 -0.12(-1.21%)
Will STTK be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STTK
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates
Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Lags Revenue Estimates
Amgen (AMGN) Q2 Earnings and Revenues Top Estimates
Other News for STTK
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference